3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent
- 1 November 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (11) , 2403-2409
- https://doi.org/10.1021/jm00161a045
Abstract
Syntheses for 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt monohydrate (9; MDL 427) and the related formamido compound, 2-(formylamino)-N-1H-tetrazol-5-ylbenzamide (10), are described. Both compounds are active in the rat passive cutaneous anaphylaxis and passive peritoneal anaphylaxis tests. A 94:6 equilibrium mixture of 9 and ionized 10, respectively, forms in aqueous buffer systems at a pH-dependent rate. In addition, analogues of 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone (8) bearing substituents on the benzene ring, substituents at the 2-position, and heteroaryl groups at the 3-position other than tetrazole were prepared. These analogue sets demonstrated that an accessible electrophilic center and an acidic functionality were requirements for good antiallergic activity.This publication has 6 references indexed in Scilit:
- Synthesis and antiallergic activity of some quinolinones and imidazoquinolinonesJournal of Medicinal Chemistry, 1985
- Synthesis and uncoupling activities of hydrophobic thioureas.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drugJournal of Allergy and Clinical Immunology, 1980
- BRL10833 in inhibiting exercise-induced bronchoconstriction in asthmatic childrenRespiratory Medicine, 1978
- Peritoneal Anaphylaxis in the Rat after Sensitisation with Mouse AntiserumInternational Archives of Allergy and Immunology, 1978
- Studies in histochemistryAnalytical Biochemistry, 1965